Amrita Singh

Amrita Singh is currently employed as a Principal Scientist in Product Characterization and Analytical Development at Fate Therapeutics Inc since January 2022. Prior to this, they worked at Astellas Pharma US, where they held the positions of Senior Scientist from October 2020 to January 2022, Scientist II from April 2019 to September 2020, and Scientist from November 2017 to March 2019. Before joining Astellas Pharma US, Amrita was associated with Thomas Jefferson University, where they held various research positions including Postdoctoral Fellow from August 2017 to November 2017, PhD Candidate from September 2012 to August 2017, and Research Assistant from August 2010 to August 2012.

Amrita Singh earned a Doctor of Philosophy (Ph.D.) degree in Cancer Biology from Jefferson Health from 2012 to 2017. Prior to that, they completed a Bachelor's degree in Biotechnology from Jefferson College of Health Professions from 2009 to 2010. Amrita also holds an Associate of Science (A.S.) degree in Allied Health Sciences from Manor College, which they obtained from 2006 to 2008. Additionally, they obtained a certification in "The Six Morning Habits of High Performers" from LinkedIn in 2021.